Welcome to the Office of Cancer Survivorship Program, DCCPS
The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.
Meet the New OCS Director
Emily S. Tonorezos, MD, MPH
Read more about Cancer Moonshot research funding announcements focused on cancer survivorship.
Statistics, Graphs and Definitions
Number of Cancer Survivors
As of January 2019, it is estimated that there are 16.9 million cancer survivors in the United States. This represents approximately 5.0% of the population.
Expertise in Cancer Survivorship Research
Want to find out whom to contact about your survivorship topic? Search for survivorship program contacts at NCI by topic area.
An individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.
OCS works to promote a better understanding of the unique needs of the growing population of cancer survivors and to enhance our ability to address those needs.
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer.
Expiration date: May 8, 2021
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 and R21).
Expiration date: July 31, 2021
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 and R21).
Expiration date: September 8, 2022